Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice.
about
Structure and receptor binding preferences of recombinant human A(H3N2) virus hemagglutininsTwo years after pandemic influenza A/2009/H1N1: what have we learned?Why does pandemic influenza virus kill?The immune profile associated with acute allergic asthma accelerates clearance of influenza virusPlaying hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection.Haemagglutinin mutations and glycosylation changes shaped the 2012/13 influenza A(H3N2) epidemic, Houston, Texas.Amino Acid Substitutions Improve the Immunogenicity of H7N7HA Protein and Protect Mice against Lethal H7N7 Viral Challenge.Pathogenic responses among young adults during the 1918 influenza pandemic.Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses.The age distribution of mortality due to influenza: pandemic and peri-pandemic.The Length of N-Glycans of Recombinant H5N1 Hemagglutinin Influences the Oligomerization and Immunogenicity of Vaccine AntigenUpdate in respiratory infections 2011.Genetic and antigenic evolution of H9N2 avian influenza viruses circulating in Egypt between 2011 and 2013.Comparative glycomics analysis of influenza Hemagglutinin (H5N1) produced in vaccine relevant cell platforms.Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy.First outbreaks and phylogenetic analyses of avian influenza H9N2 viruses isolated from poultry flocks in MoroccoA live-attenuated pneumococcal vaccine elicits CD4+ T-cell dependent class switching and provides serotype independent protection against acute otitis media.Molecular Dynamics Simulation of the Influenza A(H3N2) Hemagglutinin Trimer Reveals the Structural Basis for Adaptive Evolution of the Recent Epidemic Clade 3C.2a.Correlates of vaccine protection from influenza and its complications.Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA.Bitter-sweet symphony: glycan-lectin interactions in virus biology.Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.Migration of the swine influenza virus δ-cluster hemagglutinin N-linked glycosylation site from N142 to N144 results in loss of antibody cross-reactivity.Fatal influenza B infections: time to reexamine influenza research priorities.Site-specific glycosylation profile of influenza A (H1N1) hemagglutinin through tandem mass spectrometry.Functional role of N-linked glycosylation in pseudorabies virus glycoprotein gH.Glycosylation of Hemagglutinin and Neuraminidase of Influenza A Virus as Signature for Ecological Spillover and Adaptation among Influenza Reservoirs.Global site-specific analysis of glycoprotein N-glycan processing.The Role and Molecular Mechanism of Action of Surfactant Protein D in Innate Host Defense Against Influenza A Virus.
P2860
Q27697647-80AD2395-B19D-49BA-A960-8207BC964650Q30224656-012BA676-43ED-4081-B8D1-88283875BFD9Q30352613-1742741C-7544-40BA-8288-6F6076BF02DEQ30358384-092310CD-7121-4118-8C15-980A766F1B94Q30360290-5102B126-AF59-4EED-992F-E5B9F62FC927Q30374828-909732E7-D9FD-4239-9697-BF9A6C2B1BF8Q30375164-7A0326F8-F413-477A-9211-81643B6E6244Q30412566-7FD6D596-A469-4D88-A237-5F07AA985BEAQ30419865-4DBD89C7-1FEF-43CA-9750-480EC6F76BA6Q30424688-E81E9D7A-C1B6-4695-AD12-595C166FBA68Q33580863-33FDAADC-19E5-437A-B4DE-9A3734AF739EQ33738738-0E3BA10A-8F89-4F32-9169-B2FB1FCC3C23Q34386091-799C082A-5A71-41DB-8AE3-209A30A4596FQ34814833-4A71AC31-4D71-4654-90F0-95416E740B2FQ35650895-7888FF99-623D-44D8-BB24-C23523A481C9Q37178250-4316E319-3C8C-4ACC-AF94-8B04028EB092Q37606439-57E753EC-0C65-4597-8266-FA63DD6C4FBEQ37742902-FD763A57-D2F1-4E4B-9C7A-4CC1335CC355Q37976539-E160758D-DF5F-4AF9-935D-322E46A74179Q38050485-B52FAE21-E1DE-4B3A-A281-9A64D5C8F189Q38159719-920520D2-E0FA-44F0-818E-7F942C6ED7C4Q40097582-D72F5553-9D9C-43B1-BCF3-8A328B500A3AQ41812793-555CF516-BB70-44D5-8A24-DB83A41DEF29Q44891781-C682D334-9AF8-4CCF-AAE7-5B5E6D5341B2Q47607365-833C8AE1-72A9-4B9A-9817-6B70333E86D2Q50043291-6F96E3B6-1D49-4703-8733-56B82D5343F6Q52593678-D65D0B78-56A5-4511-8AEB-5E8E5E588A31Q53068939-CBD73E47-7183-4046-979D-3FE1EC97A138Q55397297-10D06374-5DFD-4E44-9146-C144125985A7
P2860
Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Glycan shielding of the influe ...... es to immunopathology in mice.
@ast
Glycan shielding of the influe ...... es to immunopathology in mice.
@en
type
label
Glycan shielding of the influe ...... es to immunopathology in mice.
@ast
Glycan shielding of the influe ...... es to immunopathology in mice.
@en
prefLabel
Glycan shielding of the influe ...... es to immunopathology in mice.
@ast
Glycan shielding of the influe ...... es to immunopathology in mice.
@en
P2860
P1476
Glycan shielding of the influe ...... es to immunopathology in mice.
@en
P2093
Keith Wanzeck
Kelli L Boyd
P2860
P304
P356
10.1164/RCCM.201007-1184OC
P407
P577
2010-10-08T00:00:00Z